Neurodegeneration Clinical Trials

7 recruiting

Neurodegeneration Trials at a Glance

10 actively recruiting trials for neurodegeneration are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Exeter, Boston, and Cassino. Lead sponsors running neurodegeneration studies include University of Exeter, Sanford Health, and LMU Klinikum.

Browse neurodegeneration trials by phase

Treatments under study

About Neurodegeneration Clinical Trials

Looking for clinical trials for Neurodegeneration? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neurodegeneration trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neurodegeneration clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 1

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

NeurodegenerationReproductive Disorder
Stephanie B. Seminara, MD40 enrolled1 locationNCT07224490
Recruiting
Not Applicable

Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

Movement DisordersParkinson DiseaseNeurodegeneration
VA Office of Research and Development123 enrolled1 locationNCT06088355
Recruiting
Not Applicable

Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

ObesityMetabolic SyndromeInflammation+5 more
University of Seville8 enrolled1 locationNCT07361887
Recruiting

Longitudinal Investigation of I2BS in PD

Parkinson DiseasePositron Emission TomographyNeurodegenerative Diseases+3 more
University of Exeter44 enrolled1 locationNCT05516719
Recruiting

Serotonin Release in Premotor and Motor PD

Parkinson DiseasePositron Emission TomographyNeurodegenerative Diseases+3 more
University of Exeter42 enrolled1 locationNCT05516732
Recruiting

TIRCON International NBIA Registry

Neurodegeneration With Brain Iron Accumulation (NBIA)Pantothenate Kinase-associated Neurodegeneration (PKAN)Beta-Propeller Protein-Associated Neurodegeneration (BPAN)+8 more
LMU Klinikum2,000 enrolled9 locationsNCT05522374
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+188 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

Tau PET/CT in Various Tau-Related Disease Patients

Neurodegenerative DiseasesNeurodegenerationTauopathies
Tianjin Medical University500 enrolled2 locationsNCT06690983
Recruiting

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Cognitive ImpairmentDementiaMultiple System Atrophy+15 more
Casa di Cura San Raffaele Cassino600 enrolled1 locationNCT06596746
Recruiting

China Longitudinal Aging and Cognitive Impairment Study

Alzheimer DiseaseAgingMild Cognitive Impairment+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University4,000 enrolled2 locationsNCT05468905